APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Pulmonary Drug Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Industry Research

Inhalation Pulmonary Drug Delivery Devices Industry Research Report 2026

Report ID 174002830528 December 2025136 pages

Choose your research edition.

Industry ResearchInhalation Pulmonary Drug Delivery Devices Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Pulmonary Drug Delivery Devices Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Inhalation Pulmonary Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Pulmonary Drug Delivery Devices Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Pulmonary Drug Delivery Devices Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Inhalation Pulmonary Drug Delivery Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Inhalation Pulmonary Drug Delivery Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Inhalation Pulmonary Drug Delivery Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Inhalation Pulmonary Drug Delivery Devices include AptarGroup, Boehringer Ingelheim, Chiesi Farmaceutici, H&T Presspart, Koninklijke Philips, Monaghan Medical, OMRON, PARI International and Vectura, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Inhalation Pulmonary Drug Delivery Devices market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Inhalation Pulmonary Drug Delivery Devices Market by Company

AptarGroup

Boehringer Ingelheim

Chiesi Farmaceutici

H&T Presspart

Koninklijke Philips

Monaghan Medical

OMRON

PARI International

Vectura

AstraZeneca

GlaxoSmithKline (GSK)

Viatris

Merck

Novartis

Teva Pharmaceutical Industries

Inhalation Pulmonary Drug Delivery Devices Segment by Type

Nebulizers

Dry-powder Inhalers

Metered- dose Inhalers

Inhalation Pulmonary Drug Delivery Devices Segment by Application

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis (CF)

Idiopathic Pulmonary Fibrosis (IPF)

Asthma

Others

Inhalation Pulmonary Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Pulmonary Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Pulmonary Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Pulmonary Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Inhalation Pulmonary Drug Delivery Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Inhalation Pulmonary Drug Delivery Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Inhalation Pulmonary Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Inhalation Pulmonary Drug Delivery Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Inhalation Pulmonary Drug Delivery Devices Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Manufacturers (2021-2026) Table 8. Global Inhalation Pulmonary Drug Delivery Devices Revenue of Manufacturers (2021-2026) Table 9. Global Inhalation Pulmonary Drug Delivery Devices Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Inhalation Pulmonary Drug Delivery Devices Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Inhalation Pulmonary Drug Delivery Devices Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Product Type & Application Table 14. Global Inhalation Pulmonary Drug Delivery Devices Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Inhalation Pulmonary Drug Delivery Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. AptarGroup Company Information Table 19. AptarGroup Business Overview Table 20. AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 22. AptarGroup Recent Developments Table 23. Boehringer Ingelheim Company Information Table 24. Boehringer Ingelheim Business Overview Table 25. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 27. Boehringer Ingelheim Recent Developments Table 28. Chiesi Farmaceutici Company Information Table 29. Chiesi Farmaceutici Business Overview Table 30. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 32. Chiesi Farmaceutici Recent Developments Table 33. H&T Presspart Company Information Table 34. H&T Presspart Business Overview Table 35. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 37. H&T Presspart Recent Developments Table 38. Koninklijke Philips Company Information Table 39. Koninklijke Philips Business Overview Table 40. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 42. Koninklijke Philips Recent Developments Table 43. Monaghan Medical Company Information Table 44. Monaghan Medical Business Overview Table 45. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 47. Monaghan Medical Recent Developments Table 48. OMRON Company Information Table 49. OMRON Business Overview Table 50. OMRON Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 52. OMRON Recent Developments Table 53. PARI International Company Information Table 54. PARI International Business Overview Table 55. PARI International Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 57. PARI International Recent Developments Table 58. Vectura Company Information Table 59. Vectura Business Overview Table 60. Vectura Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 62. Vectura Recent Developments Table 63. AstraZeneca Company Information Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 67. AstraZeneca Recent Developments Table 68. GlaxoSmithKline (GSK) Company Information Table 69. GlaxoSmithKline (GSK) Business Overview Table 70. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 72. GlaxoSmithKline (GSK) Recent Developments Table 73. Viatris Company Information Table 74. Viatris Business Overview Table 75. Viatris Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 77. Viatris Recent Developments Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Merck Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 82. Merck Recent Developments Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 87. Novartis Recent Developments Table 88. Teva Pharmaceutical Industries Company Information Table 89. Teva Pharmaceutical Industries Business Overview Table 90. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 92. Teva Pharmaceutical Industries Recent Developments Table 93. Global Inhalation Pulmonary Drug Delivery Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2021-2026) & (K Units) Table 95. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2021-2026) Table 96. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2027-2032) & (K Units) Table 97. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2027-2032) Table 98. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2021-2026) Table 100. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2027-2032) Table 102. North America Inhalation Pulmonary Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 104. North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 105. North America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 109. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 110. Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 114. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 115. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Inhalation Pulmonary Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 119. South America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 120. South America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 128. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2027-2032) & (K Units) Table 129. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2021-2026) Table 130. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2027-2032) Table 131. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2021-2026) Table 134. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2027-2032) Table 135. Global Inhalation Pulmonary Drug Delivery Devices Price by Type (2021-2026) & (US$/Unit) Table 136. Global Inhalation Pulmonary Drug Delivery Devices Price by Type (2027-2032) & (US$/Unit) Table 137. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 138. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2027-2032) & (K Units) Table 139. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2021-2026) Table 140. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2027-2032) Table 141. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2021-2026) Table 144. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2027-2032) Table 145. Global Inhalation Pulmonary Drug Delivery Devices Price by Application (2021-2026) & (US$/Unit) Table 146. Global Inhalation Pulmonary Drug Delivery Devices Price by Application (2027-2032) & (US$/Unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Inhalation Pulmonary Drug Delivery Devices Distributors List Table 150. Inhalation Pulmonary Drug Delivery Devices Customers List Table 151. Inhalation Pulmonary Drug Delivery Devices Industry Trends Table 152. Inhalation Pulmonary Drug Delivery Devices Industry Drivers Table 153. Inhalation Pulmonary Drug Delivery Devices Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Inhalation Pulmonary Drug Delivery Devices Product Image Figure 5. Global Inhalation Pulmonary Drug Delivery Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Inhalation Pulmonary Drug Delivery Devices Market Size (2021-2032) & (US$ Million) Figure 7. Global Inhalation Pulmonary Drug Delivery Devices Sales (2021-2032) & (K Units) Figure 8. Global Inhalation Pulmonary Drug Delivery Devices Average Price (US$/Unit) & (2021-2032) Figure 9. Nebulizers Product Image Figure 10. Dry-powder Inhalers Product Image Figure 11. Metered- dose Inhalers Product Image Figure 12. Chronic Obstructive Pulmonary Disease (COPD) Product Image Figure 13. Cystic Fibrosis (CF) Product Image Figure 14. Idiopathic Pulmonary Fibrosis (IPF) Product Image Figure 15. Asthma Product Image Figure 16. Others Product Image Figure 17. Global Inhalation Pulmonary Drug Delivery Devices Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Inhalation Pulmonary Drug Delivery Devices Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Inhalation Pulmonary Drug Delivery Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region in 2025 Figure 23. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region in 2025 Figure 24. North America Inhalation Pulmonary Drug Delivery Devices Market Size by Country in 2025 Figure 25. North America Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 26. North America Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 27. United States Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Mexico Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Inhalation Pulmonary Drug Delivery Devices Market Size by Country in 2025 Figure 31. Europe Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 32. Europe Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 33. Germany Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Russia Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Spain Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Netherlands Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Switzerland Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Sweden Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Poland Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Market Size by Country in 2025 Figure 44. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 45. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 46. China Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Japan Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South Korea Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. India Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Australia Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Taiwan Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Southeast Asia Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. South America Inhalation Pulmonary Drug Delivery Devices Market Size by Country in 2025 Figure 55. South America Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 56. South America Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 57. Brazil Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Argentina Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Chile Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size by Country in 2025 Figure 61. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 63. Egypt Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2021-2032) Figure 69. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2021-2032) Figure 70. Global Inhalation Pulmonary Drug Delivery Devices Price (US$/Unit) by Type (2021-2032) Figure 71. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2021-2032) Figure 72. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2021-2032) Figure 73. Global Inhalation Pulmonary Drug Delivery Devices Price (US$/Unit) by Application (2021-2032) Figure 74. Inhalation Pulmonary Drug Delivery Devices Value Chain Figure 75. Inhalation Pulmonary Drug Delivery Devices Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Inhalation Pulmonary Drug Delivery Devices Industry Opportunities and Challenges

Scope & coverage.

Types
  • Nebulizers
  • Dry-powder Inhalers
  • Metered- dose Inhalers
Applications
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Asthma
  • Others
Companies covered
  • AptarGroup
  • Boehringer Ingelheim
  • Chiesi Farmaceutici
  • H&T Presspart
  • Koninklijke Philips
  • Monaghan Medical
  • OMRON
  • PARI International
  • Vectura
  • AstraZeneca
  • GlaxoSmithKline (GSK)
  • Viatris
  • Merck
  • Novartis
  • Teva Pharmaceutical Industries

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Inhalation Pulmonary Drug Delivery Devices Market Size (2021-2032)
  4. 2.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales (2021-2032)
  5. 2.2.3 Global Inhalation Pulmonary Drug Delivery Devices Market Average Price (2021-2032)
  6. 2.3 Inhalation Pulmonary Drug Delivery Devices by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Nebulizers
  9. 2.3.3 Dry-powder Inhalers
  10. 2.3.4 Metered- dose Inhalers
  11. 2.4 Inhalation Pulmonary Drug Delivery Devices by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Chronic Obstructive Pulmonary Disease (COPD)
  14. 2.4.3 Cystic Fibrosis (CF)
  15. 2.4.4 Idiopathic Pulmonary Fibrosis (IPF)
  16. 2.4.5 Asthma
  17. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Inhalation Pulmonary Drug Delivery Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Inhalation Pulmonary Drug Delivery Devices Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Inhalation Pulmonary Drug Delivery Devices Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Inhalation Pulmonary Drug Delivery Devices Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Product Type & Application
  8. 3.8 Global Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Established Date
  9. 3.9 Global Inhalation Pulmonary Drug Delivery Devices Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 AptarGroup
  2. 4.1.1 AptarGroup Company Information
  3. 4.1.2 AptarGroup Business Overview
  4. 4.1.3 AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  6. 4.1.5 AptarGroup Recent Developments
  7. 4.2 Boehringer Ingelheim
  8. 4.2.1 Boehringer Ingelheim Company Information
  9. 4.2.2 Boehringer Ingelheim Business Overview
  10. 4.2.3 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  12. 4.2.5 Boehringer Ingelheim Recent Developments
  13. 4.3 Chiesi Farmaceutici
  14. 4.3.1 Chiesi Farmaceutici Company Information
  15. 4.3.2 Chiesi Farmaceutici Business Overview
  16. 4.3.3 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  18. 4.3.5 Chiesi Farmaceutici Recent Developments
  19. 4.4 H&T Presspart
  20. 4.4.1 H&T Presspart Company Information
  21. 4.4.2 H&T Presspart Business Overview
  22. 4.4.3 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  24. 4.4.5 H&T Presspart Recent Developments
  25. 4.5 Koninklijke Philips
  26. 4.5.1 Koninklijke Philips Company Information
  27. 4.5.2 Koninklijke Philips Business Overview
  28. 4.5.3 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  30. 4.5.5 Koninklijke Philips Recent Developments
  31. 4.6 Monaghan Medical
  32. 4.6.1 Monaghan Medical Company Information
  33. 4.6.2 Monaghan Medical Business Overview
  34. 4.6.3 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  36. 4.6.5 Monaghan Medical Recent Developments
  37. 4.7 OMRON
  38. 4.7.1 OMRON Company Information
  39. 4.7.2 OMRON Business Overview
  40. 4.7.3 OMRON Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  42. 4.7.5 OMRON Recent Developments
  43. 4.8 PARI International
  44. 4.8.1 PARI International Company Information
  45. 4.8.2 PARI International Business Overview
  46. 4.8.3 PARI International Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  48. 4.8.5 PARI International Recent Developments
  49. 4.9 Vectura
  50. 4.9.1 Vectura Company Information
  51. 4.9.2 Vectura Business Overview
  52. 4.9.3 Vectura Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  54. 4.9.5 Vectura Recent Developments
  55. 4.10 AstraZeneca
  56. 4.10.1 AstraZeneca Company Information
  57. 4.10.2 AstraZeneca Business Overview
  58. 4.10.3 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  60. 4.10.5 AstraZeneca Recent Developments
  61. 4.11 GlaxoSmithKline (GSK)
  62. 4.11.1 GlaxoSmithKline (GSK) Company Information
  63. 4.11.2 GlaxoSmithKline (GSK) Business Overview
  64. 4.11.3 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  66. 4.11.5 GlaxoSmithKline (GSK) Recent Developments
  67. 4.12 Viatris
  68. 4.12.1 Viatris Company Information
  69. 4.12.2 Viatris Business Overview
  70. 4.12.3 Viatris Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  72. 4.12.5 Viatris Recent Developments
  73. 4.13 Merck
  74. 4.13.1 Merck Company Information
  75. 4.13.2 Merck Business Overview
  76. 4.13.3 Merck Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Merck Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  78. 4.13.5 Merck Recent Developments
  79. 4.14 Novartis
  80. 4.14.1 Novartis Company Information
  81. 4.14.2 Novartis Business Overview
  82. 4.14.3 Novartis Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  84. 4.14.5 Novartis Recent Developments
  85. 4.15 Teva Pharmaceutical Industries
  86. 4.15.1 Teva Pharmaceutical Industries Company Information
  87. 4.15.2 Teva Pharmaceutical Industries Business Overview
  88. 4.15.3 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  90. 4.15.5 Teva Pharmaceutical Industries Recent Developments
5 Global Inhalation Pulmonary Drug Delivery Devices Market Scenario by Region
  1. 5.1 Global Inhalation Pulmonary Drug Delivery Devices Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021-2032
  3. 5.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021-2026
  4. 5.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2027-2032
  5. 5.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region: 2021-2032
  6. 5.3.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region: 2021-2026
  7. 5.3.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region: 2027-2032
  8. 5.4 North America Inhalation Pulmonary Drug Delivery Devices Market Facts & Figures by Country
  9. 5.4.1 North America Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2032)
  11. 5.4.3 North America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Inhalation Pulmonary Drug Delivery Devices Market Facts & Figures by Country
  16. 5.5.1 Europe Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2032)
  18. 5.5.3 Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Inhalation Pulmonary Drug Delivery Devices Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Inhalation Pulmonary Drug Delivery Devices Market Facts & Figures by Country
  41. 5.7.1 South America Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2032)
  43. 5.7.3 South America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2032)
  2. 6.1.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2021-2032)
  4. 6.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021-2032)
  5. 6.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Inhalation Pulmonary Drug Delivery Devices Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2032)
  2. 7.1.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2021-2032)
  4. 7.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021-2032)
  5. 7.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Inhalation Pulmonary Drug Delivery Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Inhalation Pulmonary Drug Delivery Devices Value Chain Analysis
  2. 8.1.1 Inhalation Pulmonary Drug Delivery Devices Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Inhalation Pulmonary Drug Delivery Devices Production Mode & Process
  5. 8.2 Inhalation Pulmonary Drug Delivery Devices Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Inhalation Pulmonary Drug Delivery Devices Distributors
  8. 8.2.3 Inhalation Pulmonary Drug Delivery Devices Customers
9 Global Inhalation Pulmonary Drug Delivery Devices Analyzing Market Dynamics
  1. 9.1 Inhalation Pulmonary Drug Delivery Devices Industry Trends
  2. 9.2 Inhalation Pulmonary Drug Delivery Devices Industry Drivers
  3. 9.3 Inhalation Pulmonary Drug Delivery Devices Industry Opportunities and Challenges
  4. 9.4 Inhalation Pulmonary Drug Delivery Devices Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst